← FDA Drug Approvals (Drugs@FDA)
REMODULIN
NDA · New Drug Application · Sponsor: UNITED THERAP · Approved 2002-05-21
Drug application
- FDA Application #
NDA021272- Application type
- New Drug Application
- Brand name
- REMODULIN
- Generic name
- TREPROSTINIL
- Active ingredients
- TREPROSTINIL
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- UNITED THERAP
- Manufacturer
- United Therapeutics Corporation
- First approval
- 2002-05-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown